My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 104

    1.

    Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome.

    Salomons GS, Smets LA, Verwijs-Janssen M, Hart AA, Haarman EG, Kaspers GJ, Wering EV, Der Does-Van Den Berg AV, Kamps WA.

    Leukemia. 1999 Oct;13(10):1574-80.PMID: 10516759 [PubMed - indexed for MEDLINE]Related articles

    2.

    In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia.

    Kaspers GJ, Veerman AJ, Pieters R, Van Zantwijk CH, Smets LA, Van Wering ER, Van Der Does-Van Den Berg A.

    Blood. 1997 Oct 1;90(7):2723-9.PMID: 9326239 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, L-asparaginase, and vincristine in childhood acute lymphoblastic leukemia.

    Hongo T, Yamada S, Yajima S, Watanabe C, Fujii Y, Kawasaki H, Yazaki M, Hanada R, Horikoshi Y.

    Int J Hematol. 1999 Dec;70(4):268-77.PMID: 10643153 [PubMed - indexed for MEDLINE]Related articles

    4.

    Expression of apoptosis regulators Bcl-2 and Bax in childhood acute lymphoblastic leukemia.

    Narayan S, Chandra J, Sharma M, Naithani R, Sharma S.

    Hematology. 2007 Feb;12(1):39-43.PMID: 17364991 [PubMed - indexed for MEDLINE]Related articles

    5.

    Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs.

    Kaspers GJ, Pieters R, Van Zantwijk CH, Van Wering ER, Van Der Does-Van Den Berg A, Veerman AJ.

    Blood. 1998 Jul 1;92(1):259-66.PMID: 9639525 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Diversity of the apoptotic response to chemotherapy in childhood leukemia.

    Liu T, Raetz E, Moos PJ, Perkins SL, Bruggers CS, Smith F, Carroll WL.

    Leukemia. 2002 Feb;16(2):223-32.PMID: 11840289 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Prognostic role of bcl-xL and p53 in childhood acute lymphoblastic leukemia (ALL).

    Addeo R, Caraglia M, Baldi A, D'Angelo V, Casale F, Crisci S, Abbruzzese A, Vincenze B, Campioni M, Di Tullio MT, Indolfi P.

    Cancer Biol Ther. 2005 Jan;4(1):32-8. Epub 2004 Jan 15.PMID: 15684603 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Increased BAX expression is associated with an increased risk of relapse in childhood acute lymphocytic leukemia.

    Hogarth LA, Hall AG.

    Blood. 1999 Apr 15;93(8):2671-8.PMID: 10194447 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.

    Den Boer ML, Harms DO, Pieters R, Kazemier KM, Gobel U, Körholz D, Graubner U, Haas RJ, Jorch N, Spaar HJ, Kaspers GJ, Kamps WA, Van der Does-Van den Berg A, Van Wering ER, Veerman AJ, Janka-Schaub GE.

    J Clin Oncol. 2003 Sep 1;21(17):3262-8.PMID: 12947061 [PubMed - indexed for MEDLINE]Related articles

    10.

    Determination of the in vivo effects of prednisone on Bcl-2 family protein expression in childhood acute lymphoblastic leukemia.

    Casale F, Addeo R, D'Angelo V, Indolfi P, Poggi V, Morgera C, Crisci S, Di Tullio MT.

    Int J Oncol. 2003 Jan;22(1):123-8.PMID: 12469194 [PubMed - indexed for MEDLINE]Related articles

    11.

    In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia.

    Wuchter C, Ruppert V, Schrappe M, Dörken B, Ludwig WD, Karawajew L.

    Blood. 2002 Jun 1;99(11):4109-15.PMID: 12010814 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    BCL-2 expression in childhood leukemia versus spontaneous apoptosis, drug induced apoptosis, and in vitro drug resistance.

    Haarman EG, Kaspers GJ, Pieters R, van Zantwijk CH, Broekema GJ, Hählen K, Veerman AJ.

    Adv Exp Med Biol. 1999;457:325-33.PMID: 10500808 [PubMed - indexed for MEDLINE]Related articles

    13.

    Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.

    Paolucci G, Vecchi V, Favre C, Miniero R, Madon E, Pession A, Rondelli R, De Rossi G, Lo Nigro L, Porta F, Santoro N, Indolfi P, Basso G, Conter V, Aricò M; Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).

    Haematologica. 2001 May;86(5):478-84.PMID: 11410410 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.

    Manabe A, Ohara A, Hasegawa D, Koh K, Saito T, Kiyokawa N, Kikuchi A, Takahashi H, Ikuta K, Hayashi Y, Hanada R, Tsuchida M; Tokyo Children's Cancer Study Group.

    Haematologica. 2008 Aug;93(8):1155-60. Epub 2008 Jun 2.PMID: 18519521 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia.

    Karawajew L, Ruppert V, Wuchter C, Kösser A, Schrappe M, Dörken B, Ludwig WD.

    Blood. 2000 Jul 1;96(1):297-306.PMID: 10891465 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype.

    Steinbach D, Wittig S, Cario G, Viehmann S, Mueller A, Gruhn B, Haefer R, Zintl F, Sauerbrey A.

    Blood. 2003 Dec 15;102(13):4493-8. Epub 2003 Jun 19.PMID: 12816874 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members.

    Laane E, Panaretakis T, Pokrovskaja K, Buentke E, Corcoran M, Söderhäll S, Heyman M, Mazur J, Zhivotovsky B, Porwit A, Grandér D.

    Haematologica. 2007 Nov;92(11):1460-9.PMID: 18024393 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.

    Stams WA, den Boer ML, Beverloo HB, Meijerink JP, van Wering ER, Janka-Schaub GE, Pieters R.

    Clin Cancer Res. 2005 Apr 15;11(8):2974-80.PMID: 15837750 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Childhood acute lymphoblastic leukemia: prognostic value of initial peripheral blast count in good responders to prednisone.

    Felice MS, Zubizarreta PA, Alfaro EM, Sackmann-Muriel F.

    J Pediatr Hematol Oncol. 2001 Oct;23(7):411-5.PMID: 11878573 [PubMed - indexed for MEDLINE]Related articles

    20.

    Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.

    Wuchter C, Karawajew L, Ruppert V, Schrappe M, Harbott J, Ratei R, Dörken B, Ludwig WD.

    Br J Haematol. 2000 Jul;110(1):154-60.PMID: 10930993 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity